PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27332749-6	2017	Pre-treatment with PGRN (100 ng mL-1 ) augmented ACh (10 mum)-induced nitric oxide (NO)-mediated relaxation in the presence of indomethacin (10 mum), a cyclooxygenase inhibitor, and tetraethyl ammonium (10 mm), a non-selective potassium channel blocker.	Nitric Oxide	70-82	L1 cell adhesion molecule	Mus musculus	32-36	
35424863-5	2022	Substrate 1 (IC50 = 23.9 +- 0.2 mug mL-1) showed a remarkable anti-inflammatory activity against nitric oxide (NO) production, in comparison to standard LNMMA (IC50 = 24.2 +- 0.8 mug mL-1).	Nitric Oxide	97-109	L1 cell adhesion molecule	Mus musculus	36-40	
32025498-6	2020	ODG (8.75-140.00 mug mL-1) was found to reduce nitric oxide production by 41.6 %, while the antioxidant standard ascorbic acid (AA) reduced 54.14 %.	Nitric Oxide	47-59	L1 cell adhesion molecule	Mus musculus	21-25	
29291791-2	2018	Nitrite is on-line reduced to volatile nitric oxide (NO) by 1.5% (m/v) ascorbic acid and 1.0 mol L-1 hydrochloric acid.	Nitric Oxide	39-51	L1 cell adhesion molecule	Mus musculus	97-100